Ultragenyx Pharma (RARE) PT Lowered to $47 at Wedbush
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $44.12 -2.19%
Rating Summary:
20 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
20 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $47.00 (from $48.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Ultragenyx Pharma (RARE) PT Raised to $61 at TD Cowen
- Lynas Corporation Limited (LYC:AU) (LYSDY) PT Raised to AUD7 at Canaccord Genuity
- Beijing Oriental Yuhong (002271:CH) PT Lowered to RMB25 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
